
Company Number
09341444
Next Accounts
Dec 2025
Shareholders
crf health group limited
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
1 london street, reading, berkshire, RG1 4PN
Website
www.crfhealth.comPomanda estimates the enterprise value of CRF HEALTH TECHNOLOGIES LIMITED at £0 based on a Turnover of £0 and 1.17x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of CRF HEALTH TECHNOLOGIES LIMITED at £0 based on an EBITDA of £-232.9k and a 4.66x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of CRF HEALTH TECHNOLOGIES LIMITED at £190.2m based on Net Assets of £119.4m and 1.59x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Crf Health Technologies Limited is a live company located in berkshire, RG1 4PN with a Companies House number of 09341444. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in December 2014, it's largest shareholder is crf health group limited with a 100% stake. Crf Health Technologies Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Pomanda's financial health check has awarded Crf Health Technologies Limited a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 1 areas for improvement. Company Health Check FAQs
1 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Crf Health Technologies Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Crf Health Technologies Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Crf Health Technologies Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Crf Health Technologies Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (46)
- Crf Health Technologies Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Crf Health Technologies Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Crf Health Technologies Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Crf Health Technologies Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Crf Health Technologies Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Crf Health Technologies Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Crf Health Technologies Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.1%, this is a lower level of debt than the average (51.3%)
- - Crf Health Technologies Limited
- - Industry AVG
Crf Health Technologies Limited's latest turnover from March 2024 is 0 and the company has net assets of £119.4 million. According to their latest financial statements, we estimate that Crf Health Technologies Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 289,366,848 | 149,809,968 | ||||||||
Other Income Or Grants | ||||||||||
Cost Of Sales | 133,657,251 | 75,624,082 | ||||||||
Gross Profit | 155,709,597 | 74,185,886 | ||||||||
Admin Expenses | -2,913,156 | 158,308,716 | 183,831,736 | |||||||
Operating Profit | -232,942 | -565,009 | -1,546,087 | 2,913,156 | -2,599,119 | -109,645,850 | -212,802 | -4,455 | -4,417 | |
Interest Payable | 89,525,784 | 52,206,098 | 17,296,561 | 21,754,277 | 20,360,456 | 3,392,455 | ||||
Interest Receivable | 15,389,509 | 4,318 | 1,727 | 1,264,896 | 4,403,064 | 4,679,742 | 973,351 | |||
Pre-Tax Profit | -232,942 | -565,009 | -1,546,087 | 18,302,666 | -92,120,584 | -161,850,220 | 41,041,028 | -17,996,258 | -15,685,131 | -2,419,104 |
Tax | 16,558,694 | 22,777,922 | 225,570 | |||||||
Profit After Tax | -232,942 | -565,009 | -1,546,087 | 18,302,666 | -75,561,890 | -139,072,299 | 41,266,599 | -17,996,258 | -15,685,131 | -2,419,104 |
Dividends Paid | ||||||||||
Retained Profit | -232,942 | -565,009 | -1,546,087 | 18,302,666 | -75,561,890 | -139,072,299 | 41,266,599 | -17,996,258 | -15,685,131 | -2,419,104 |
Employee Costs | 125,560,162 | 71,905,502 | ||||||||
Number Of Employees | 1,768 | 1,610 | ||||||||
EBITDA* | -232,942 | -565,009 | -1,546,087 | 2,913,156 | 64,109,009 | -70,145,980 | -212,802 | -4,455 | -4,417 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 52,812,473 | 18,693,098 | 148,792,135 | 178,756,237 | 204,009,188 | 195,242,256 | ||||
Intangible Assets | 1,509,963,721 | 1,559,343,526 | ||||||||
Investments & Other | 144,173,137 | 144,173,137 | 151,770,435 | 150,073,947 | 148,566,564 | 155,502,494 | 154,395,264 | 151,237,238 | ||
Debtors (Due After 1 year) | 3,469,810 | 9,431,631 | ||||||||
Total Fixed Assets | 144,173,137 | 144,173,137 | 151,770,435 | 150,073,947 | 1,562,776,194 | 1,578,036,624 | 148,792,134 | 178,756,236 | 204,009,188 | 195,242,256 |
Stock & work in progress | 5,740,692 | 5,979,960 | ||||||||
Trade Debtors | 60,215,945 | 58,870,174 | ||||||||
Group Debtors | 3,298,364 | 3,298,364 | 3,472,173 | 3,433,361 | 2,934,116 | 8,393,620 | 2,733,457 | |||
Misc Debtors | 24,014,857 | 23,499,179 | ||||||||
Cash | 39,558,607 | 26,509,458 | ||||||||
misc current assets | 17,621,145 | 16,436,037 | ||||||||
total current assets | 3,298,364 | 3,298,364 | 3,472,174 | 3,433,362 | 147,151,248 | 131,294,809 | 2,934,116 | 8,393,621 | 2,733,457 | |
total assets | 147,471,502 | 147,471,502 | 155,242,609 | 153,507,309 | 1,709,927,442 | 1,709,331,433 | 151,726,250 | 187,149,857 | 206,742,645 | 195,242,256 |
Bank overdraft | ||||||||||
Bank loan | ||||||||||
Trade Creditors | 8,724,195 | 9,543,923 | ||||||||
Group/Directors Accounts | 28,091,855 | 27,858,913 | 28,732,174 | 26,882,201 | 1 | |||||
other short term finances | 18,193,832 | 10,159,799 | ||||||||
hp & lease commitments | 7,856,957 | |||||||||
other current liabilities | 120,943,247 | 133,724,624 | 5,005,957 | 7,600,676 | 4,488,912 | 1,877,487 | ||||
total current liabilities | 28,091,855 | 27,858,913 | 28,732,174 | 26,882,201 | 155,718,234 | 153,428,349 | 5,005,958 | 7,600,677 | 4,488,912 | 1,877,487 |
loans | 1,766,787,595 | 1,574,026,086 | 226,479,400 | 386,470,064 | 392,236,062 | 383,393,320 | ||||
hp & lease commitments | 33,390,342 | |||||||||
Accruals and Deferred Income | 58,763,064 | 56,837,695 | ||||||||
other liabilities | 26,134,661 | 21,818,424 | 23,496,775 | 3,309,396 | ||||||
provisions | 133,488,814 | 194,115,918 | ||||||||
total long term liabilities | 1,008,901,269 | 940,908,698 | 139,374,361 | 215,053,456 | 219,614,806 | 195,006,056 | ||||
total liabilities | 28,091,855 | 27,858,913 | 28,732,174 | 26,882,201 | 1,164,619,503 | 1,094,337,047 | 144,380,319 | 222,654,133 | 224,103,718 | 196,883,543 |
net assets | 119,379,646 | 119,612,589 | 126,510,435 | 126,625,107 | 545,307,939 | 614,994,385 | 7,345,931 | -35,504,276 | -17,361,073 | -1,641,287 |
total shareholders funds | 119,379,646 | 119,612,589 | 126,510,435 | 126,625,107 | 545,307,938 | 614,994,385 | 7,345,931 | -35,504,277 | -17,361,074 | -1,641,287 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||
Operating Profit | -232,942 | -565,009 | -1,546,087 | 2,913,156 | -2,599,119 | -109,645,850 | -212,802 | -4,455 | -4,417 | |
Depreciation | 6,360,888 | 3,442,170 | ||||||||
Amortisation | 60,347,240 | 36,057,700 | ||||||||
Tax | 16,558,694 | 22,777,922 | 225,570 | |||||||
Stock | -5,740,692 | -239,268 | 5,979,960 | |||||||
Debtors | -173,809 | 38,812 | -84,267,251 | -4,100,372 | 88,866,868 | -5,459,504 | 5,660,163 | 2,733,457 | ||
Creditors | -8,724,195 | -819,729 | 9,543,923 | |||||||
Accruals and Deferred Income | -179,706,311 | -10,856,008 | 185,556,362 | -2,594,719 | 3,111,764 | 2,611,425 | 1,877,487 | |||
Deferred Taxes & Provisions | -133,488,814 | -60,627,104 | 194,115,918 | |||||||
Cash flow from operations | -232,942 | -391,200 | -1,584,899 | -228,998,221 | 12,704,502 | 247,001,317 | 2,877,553 | -2,552,854 | -126,449 | 1,877,487 |
Investing Activities | ||||||||||
capital expenditure | ||||||||||
Change in Investments | -7,597,297 | 1,696,488 | 150,073,947 | -148,566,564 | -6,935,930 | 1,107,230 | 3,158,026 | 151,237,238 | ||
cash flow from investments | ||||||||||
Financing Activities | ||||||||||
Bank loans | ||||||||||
Group/Directors Accounts | 232,942 | -873,261 | 1,849,973 | 26,882,201 | -1 | |||||
Other Short Term Loans | -18,193,832 | 8,034,033 | 10,159,799 | |||||||
Long term loans | -1,766,787,595 | 192,761,509 | 1,347,546,686 | -159,990,664 | -5,765,998 | 8,842,742 | 383,393,320 | |||
Hire Purchase and Lease Commitments | -41,247,299 | 41,247,299 | ||||||||
other long term liabilities | -26,134,661 | 4,316,237 | -1,678,351 | 20,187,379 | 3,309,396 | |||||
share issue | ||||||||||
interest | 15,389,509 | -89,521,466 | -52,204,371 | -16,031,665 | -17,351,213 | -15,680,714 | -2,419,104 | |||
cash flow from financing | 232,942 | -7,206,098 | 3,281,387 | -2,220,942,513 | 158,396,818 | 2,026,088,205 | -170,122,483 | -24,942,506 | 13,314,751 | 385,061,429 |
cash and cash equivalents | ||||||||||
cash | -39,558,607 | 13,049,149 | 26,509,458 | |||||||
overdraft | ||||||||||
change in cash | -39,558,607 | 13,049,149 | 26,509,458 |
Perform a competitor analysis for crf health technologies limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in RG1 area or any other competitors across 12 key performance metrics.
CRF HEALTH TECHNOLOGIES LIMITED group structure
Crf Health Technologies Limited has no subsidiary companies.
Ultimate parent company
2 parents
CRF HEALTH TECHNOLOGIES LIMITED
09341444
Crf Health Technologies Limited currently has 3 directors. The longest serving directors include Mr Roger Smith (Oct 2020) and Mr Michael Tucker (Nov 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Roger Smith | England | 53 years | Oct 2020 | - | Director |
Mr Michael Tucker | United Kingdom | 67 years | Nov 2023 | - | Director |
Mr Swen Aron | England | 47 years | Aug 2024 | - | Director |
P&L
March 2024turnover
0
0%
operating profit
-232.9k
-59%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
119.4m
0%
total assets
147.5m
0%
cash
0
0%
net assets
Total assets minus all liabilities
company number
09341444
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
December 2014
age
11
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
March 2024
previous names
chelsea midco limited (December 2015)
accountant
-
auditor
-
address
1 london street, reading, berkshire, RG1 4PN
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to crf health technologies limited. Currently there are 3 open charges and 2 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CRF HEALTH TECHNOLOGIES LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|